With a market capitalisation of just ₹87.00 crores, Shri Vasuprada operates in the highly competitive and cyclical tea plantation industry, where volatile commodity prices and rising labour costs continue to pressure profitability. The company's Q1 FY27 performance underscores the structural challenges facing the business, with losses persisting despite a sequential revenue improvement of 43.61% from Q4 FY26's ₹22.86 crores.
The quarter's results reveal a troubling pattern: whilst the company managed to grow its top line, profitability remains elusive. Operating profit before depreciation, interest, tax, and other income stood at a meagre ₹1.08 crores, translating to an operating margin of just 3.29%—a far cry from the 8.57% margin achieved in December 2024. Employee costs, which consumed ₹19.27 crores or 58.7% of revenue, continue to be a significant drag on profitability.
| Metric | Jun'26 | Mar'26 | Dec'25 | Sep'25 | Jun'25 |
|---|---|---|---|---|---|
| Net Sales (₹ Cr) | 32.83 | 22.86 | 45.62 | 46.91 | 28.23 |
| QoQ Change (%) | +43.61% | -49.89% | -2.75% | +66.17% | — |
| YoY Change (%) | +16.29% | -30.45% | +24.47% | — | — |
| Net Profit (₹ Cr) | -1.70 | -6.56 | 5.13 | -0.84 | -4.85 |
| QoQ Change (%) | -74.09% | -227.88% | -710.71% | -82.68% | — |
| YoY Change (%) | -64.95% | -941.03% | -43.25% | — | — |
| Operating Margin (%) | 3.29% | 4.99% | 6.38% | 4.58% | -9.88% |
| PAT Margin (%) | -5.18% | -28.70% | 11.25% | -1.79% | -17.18% |
Financial Performance: Revenue Growth Masks Profitability Erosion
Shri Vasuprada's Q1 FY27 top-line performance showed resilience, with net sales climbing 16.29% year-on-year to ₹32.83 crores from ₹28.23 crores in Q1 FY26. The sequential improvement was even more pronounced, with revenue surging 43.61% from the previous quarter's ₹22.86 crores. However, this revenue expansion failed to translate into bottom-line improvement, exposing the company's weak operating leverage and cost control challenges.
The operating profit before depreciation, interest, tax, and other income (PBDIT excluding other income) stood at ₹1.08 crores in Q1 FY27, yielding a wafer-thin operating margin of 3.29%. Whilst this represents a sequential improvement from Q4 FY26's 4.99% margin, it pales in comparison to the 8.57% margin achieved in December 2024, highlighting the company's inability to sustain operational efficiency.
Employee costs remain the single largest expense category, consuming ₹19.27 crores or 58.7% of revenue in Q1 FY27, up from ₹18.43 crores in the year-ago quarter. This represents a 4.56% year-on-year increase in absolute terms, slightly outpacing revenue growth and squeezing margins. The labour-intensive nature of tea plantation operations leaves little room for cost optimisation without impacting productivity.
Interest expenses climbed to ₹1.67 crores in Q1 FY27 from ₹1.59 crores in Q1 FY26, marking a 5.03% increase that reflects the company's persistent reliance on debt financing. With depreciation charges of ₹1.58 crores remaining relatively stable, the combined burden of interest and depreciation totalled ₹3.25 crores—more than three times the operating profit generated during the quarter.
Operational Challenges: Weak Returns Signal Structural Issues
The company's return metrics paint a concerning picture of capital efficiency. The average return on capital employed (ROCE) stands at a dismal -5.11%, indicating that the business is destroying value rather than creating it. Similarly, the average return on equity (ROE) languishes at 0.0%, reflecting the company's chronic inability to generate returns for shareholders. These metrics are particularly troubling for a capital-intensive business like tea plantations, where significant investments in land, machinery, and working capital are required.
The balance sheet as of March 2025 reveals shareholder funds of ₹126.48 crores, comprising share capital of ₹29.29 crores and reserves of ₹97.19 crores. Long-term debt stood at ₹29.73 crores, resulting in a net debt-to-equity ratio of 0.51—a moderate leverage level that nonetheless contributes to the interest burden constraining profitability. Current assets of ₹33.89 crores against current liabilities of ₹41.56 crores suggest working capital pressures, with the company maintaining minimal cash reserves.
Fixed assets valued at ₹129.26 crores as of March 2025 represent the bulk of the company's asset base, comprising tea estates, processing facilities, and related infrastructure. The modest depreciation charge of ₹1.58 crores per quarter suggests limited capital expenditure in recent periods, which could pose challenges for maintaining competitiveness and productivity over the long term.
Critical Profitability Concern
Negative ROCE of -5.11%: The company's average return on capital employed has been deeply negative, indicating persistent value destruction. With an operating margin of just 3.29% in Q1 FY27, the business generates insufficient operating profit to cover its interest burden (₹1.67 crores) and depreciation (₹1.58 crores), resulting in pre-tax losses. This structural weakness requires urgent management attention through either revenue enhancement, aggressive cost reduction, or operational restructuring.
Industry Context: Tea Sector Headwinds Intensify
The tea plantation industry in India faces a confluence of challenges that have intensified in recent years. Rising labour costs, driven by statutory wage increases and social security obligations, have squeezed margins across the sector. Climate variability affecting crop yields, volatile auction prices for tea, and increasing competition from international producers have further complicated the operating environment.
Shri Vasuprada's employee cost ratio of 58.7% of revenue in Q1 FY27 reflects the labour-intensive nature of tea cultivation and processing. This ratio is significantly higher than many other manufacturing sectors, leaving limited room for margin expansion without substantial productivity improvements or pricing power. The company's inability to pass on cost increases to customers, as evidenced by the modest operating margins, suggests weak bargaining power in the marketplace.
The five-year sales growth of 6.09% indicates tepid demand expansion, barely keeping pace with inflation. More concerning is the five-year EBIT growth of -3.18%, demonstrating that revenue gains have not translated into improved profitability. This disconnect between top-line and bottom-line performance is a red flag for investors, suggesting structural inefficiencies or an increasingly competitive pricing environment.
Valuation Analysis: Distressed Pricing Reflects Fundamental Weakness
Trading at ₹101.14 as of August 05, 2026, Shri Vasuprada's shares are valued at just 0.70 times book value, a significant discount to the company's net asset value per share of ₹127.31. This price-to-book ratio of 0.70x suggests the market assigns little value to the company's ongoing business operations, viewing the assets as worth more in liquidation than as a going concern.
The company's loss-making status renders traditional earnings-based valuation metrics like P/E ratio meaningless. The enterprise value to EBITDA multiple of 42.33x appears elevated, but this is primarily a function of the minimal EBITDA base rather than an expensive valuation. With an EV-to-sales ratio of 1.01x, the market is essentially valuing the business at slightly above one year's revenue—a modest multiple that reflects the poor profitability profile.
The stock's valuation grade of "Attractive" should be interpreted with caution. Whilst the price-to-book discount and low EV-to-sales multiple suggest statistical cheapness, the fundamental weakness in profitability and returns makes this a classic value trap. The absence of dividend payments (dividend yield of NA) means investors have no income whilst waiting for a turnaround that may never materialise.
Peer Comparison: Underperformance Across Key Metrics
Comparing Shri Vasuprada with peers in the FMCG sector reveals the company's relative weakness. Whilst direct tea plantation comparables are limited in the provided peer set, the comparison nonetheless highlights significant performance gaps.
| Company | P/E (TTM) | P/BV | ROE (%) | Debt/Equity | Div Yield |
|---|---|---|---|---|---|
| Shri Vasuprada | NA (Loss Making) | 0.70x | 0.0% | 0.51 | NA |
| Pee Cee Cosma | 11.82x | 1.76x | 17.32% | -0.38 | 0.80% |
| Modern Dairies | 16.88x | 1.49x | 37.89% | 0.02 | NA |
| Terai Tea Co | 16.34x | 0.51x | 4.28% | -0.09 | NA |
| Ravelcare | 17.03x | 2.34x | 0.0% | 0.00 | NA |
| Palash Securities | 5.48x | 0.18x | 0.66% | 0.00 | NA |
Shri Vasuprada's ROE of 0.0% compares unfavourably to profitable peers like Pee Cee Cosma (17.32% ROE) and Modern Dairies (37.89% ROE). Even amongst the weaker performers in the peer group, the company's inability to generate positive returns stands out. The price-to-book ratio of 0.70x, whilst appearing attractive, is actually in line with other struggling businesses in the peer set, suggesting the market appropriately prices in the fundamental challenges.
Shareholding Pattern: Stable Promoter Base, Minimal Institutional Interest
The shareholding structure of Shri Vasuprada has remained remarkably stable over the past five quarters, with promoter holding steady at 74.89%. This substantial promoter stake, held through a network of group companies and individuals including The Oriental Company Limited (14.33%), Gloster Limited (13.01%), and family members of the Bangur family, provides governance stability but also raises questions about the lack of capital infusion to support turnaround efforts.
| Shareholder Category | Jun'26 | Mar'26 | Dec'25 | Sep'25 | Change (QoQ) |
|---|---|---|---|---|---|
| Promoter Holding | 74.89% | 74.89% | 74.89% | 74.89% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Mutual Fund Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Insurance Holdings | 2.26% | 2.26% | 2.26% | 2.26% | 0.00% |
| Other DII Holdings | 0.03% | 0.03% | 0.03% | 0.03% | 0.00% |
| Non-Institutional | 22.82% | 22.82% | 22.82% | 22.82% | 0.00% |
The complete absence of FII and mutual fund holdings signals institutional investors' lack of confidence in the company's prospects. Total institutional holding stands at a mere 2.29%, comprising primarily insurance company stakes. This institutional void is particularly telling, as sophisticated investors with deep research capabilities have clearly chosen to avoid the stock despite its low valuation.
The frozen shareholding pattern—with zero change across all categories for multiple quarters—suggests a lack of liquidity and investor interest. With just 99 shares traded on August 05, 2026, the stock exhibits extremely low liquidity, making it difficult for investors to enter or exit positions without significant price impact.
Stock Performance: Sustained Underperformance Across All Timeframes
Shri Vasuprada's stock performance has been dismal across virtually all timeframes, with the shares declining 17.77% over the past year compared to the Sensex's 2.64% decline—resulting in a negative alpha of 15.13 percentage points. The one-year underperformance extends to sector comparison, with the stock lagging the FMCG sector by 22.59 percentage points.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | -5.48% | +1.19% | -6.67% |
| 1 Month | +0.14% | +1.05% | -0.91% |
| 3 Months | -2.19% | +2.03% | -4.22% |
| 6 Months | -6.74% | -5.68% | -1.06% |
| YTD | -6.35% | -7.79% | +1.44% |
| 1 Year | -17.77% | -2.64% | -15.13% |
| 2 Years | +2.28% | -0.23% | +2.51% |
| 3 Years | +37.06% | +19.57% | +17.49% |
The recent price action has been particularly weak, with the stock declining 5.48% over the past week and trading below all key moving averages—the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This technical weakness aligns with the fundamental deterioration, as the market continues to price in the company's persistent losses and weak operational performance.
The stock's high beta of 1.50 indicates significantly higher volatility than the broader market, with an annualised volatility of 48.44% compared to the Sensex's 13.56%. This elevated volatility, combined with negative returns, places the stock firmly in the "high risk, low return" category—an unattractive combination for most investors. The risk-adjusted return of -0.37 over the past year compares unfavourably to the Sensex's -0.19, indicating that investors have not been compensated for the additional risk undertaken.
Investment Thesis: Weak Fundamentals Across All Parameters
The investment case for Shri Vasuprada is severely compromised by weak performance across all four key assessment parameters. The company's quality grade of "Below Average" reflects its poor long-term financial performance, with negative average ROCE and ROE signalling chronic value destruction. The financial trend is classified as "Flat" for Q1 FY27, offering no evidence of improvement trajectory.
From a technical perspective, the stock remains in a "Mildly Bearish" trend as of August 03, 2026, having recently transitioned from a "Bearish" classification. The MACD indicator shows mixed signals (mildly bullish on weekly, bearish on monthly), whilst moving averages point to continued weakness. The stock's position below all major moving averages reinforces the negative technical outlook.
The valuation, whilst appearing statistically cheap at 0.70x book value, represents a value trap rather than an opportunity. The "Attractive" valuation grade must be viewed in context of the company's inability to generate profits or returns. Without a clear path to profitability improvement, the discount to book value merely reflects the market's rational assessment of impaired earning power.
Key Strengths & Risk Factors
✓ KEY STRENGTHS
- Revenue Growth: Q1 FY27 sales grew 16.29% YoY to ₹32.83 crores, demonstrating some demand resilience
- Stable Promoter Base: 74.89% promoter holding provides governance stability and long-term commitment
- No Pledging: Zero promoter pledging indicates financial discipline at ownership level
- Moderate Leverage: Net debt-to-equity of 0.51 is manageable compared to highly leveraged peers
- Asset Base: Fixed assets of ₹129.26 crores provide tangible backing, reflected in book value of ₹127.31 per share
- Valuation Discount: Trading at 0.70x book value offers potential upside if turnaround materialises
⚠ KEY CONCERNS
- Chronic Losses: Net loss of ₹1.70 crores in Q1 FY27, deepening 64.95% YoY despite revenue growth
- Negative Returns: Average ROCE of -5.11% and ROE of 0.0% indicate persistent value destruction
- Wafer-Thin Margins: Operating margin of just 3.29% insufficient to cover interest and depreciation burden
- High Labour Costs: Employee costs at 58.7% of revenue leave minimal room for margin expansion
- Zero Institutional Interest: No FII or MF holdings signal lack of sophisticated investor confidence
- Weak Stock Performance: Down 17.77% over one year, underperforming sector by 22.59 percentage points
- Technical Weakness: Trading below all major moving averages in mildly bearish trend
- Illiquidity: Minimal trading volumes (99 shares on Aug 05) make entry/exit difficult
Outlook: What to Watch in Coming Quarters
POSITIVE CATALYSTS
- Margin Improvement: Operating margins expanding beyond 5-6% range consistently
- Cost Rationalisation: Employee cost ratio declining below 55% of revenue
- Profitability Achievement: Sustained quarterly profits demonstrating operational turnaround
- Debt Reduction: Declining interest burden through debt paydown or refinancing
- Institutional Entry: Mutual fund or FII stake building signalling confidence
RED FLAGS
- Continued Losses: Inability to achieve profitability in upcoming quarters
- Margin Compression: Operating margins falling below 3% due to cost pressures
- Rising Debt: Increasing leverage to fund working capital or operational losses
- Revenue Decline: Top-line contraction indicating demand weakness or market share loss
- Promoter Selling: Any reduction in promoter stake would signal loss of confidence
The Verdict: Avoid This Value Trap
Score: 17/100
For Fresh Investors: Avoid entirely. The combination of chronic losses, negative returns on capital, wafer-thin margins, and weak technical trends makes this an unattractive investment despite the low price-to-book ratio. The absence of institutional interest and minimal liquidity create additional risks. Better opportunities exist elsewhere in the FMCG and plantation sectors.
For Existing Holders: Consider exiting on any technical bounce. The Q1 FY27 results demonstrate that revenue growth alone is insufficient to drive profitability given the company's cost structure. Without evidence of meaningful margin expansion or operational improvement, the stock is likely to remain under pressure. The 30% discount to book value is justified given the poor return profile.
Fair Value Estimate: ₹75-80 (26-21% downside from current levels), reflecting continued losses and weak fundamentals. Current price of ₹101.14 offers no margin of safety.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. The author and publication hold no positions in the securities discussed and have no business relationship with the company.
